Projects per year
Personal profile
Campus career
附属病院 助教 2008/04/01-2017/06/30
附属病院 講師 2017/07/01-2019/05/31
医学科 准教授 2019/06/01-2019/09/30
分子病態医学系 准教授 2019/06/01-2019/09/30
医学科 准教授 2019/10/01-
医学系 准教授 2019/10/01-
医学部医学科 基幹教員
学部運営への参画状況・・・有-教務委員会他
担当授業科目に係る状況・・・主要授業科目担当
附属病院 講師 2017/07/01-2019/05/31
医学科 准教授 2019/06/01-2019/09/30
分子病態医学系 准教授 2019/06/01-2019/09/30
医学科 准教授 2019/10/01-
医学系 准教授 2019/10/01-
医学部医学科 基幹教員
学部運営への参画状況・・・有-教務委員会他
担当授業科目に係る状況・・・主要授業科目担当
Research interests
抗原特異的細胞の検出,抗原特異的抗体の取得
肝細胞癌の治療法の開発
肝疾患の病態の免疫学的解析
肝細胞癌の治療法の開発
肝疾患の病態の免疫学的解析
Research Fields, Keywords
- Hepatology
- Immunology
Field of expertise (Grants-in-aid for Scientific Research classification)
- Gastroenterology
Fingerprint
Dive into the research topics where Kazuto Tajiri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Large-HBs抗原解析によるB型肝炎ウイルス感染症の病態解明と新規バイオマーカーの開発
Tajiri, K. (Principal Investigator)
Japan Society for the Promotion of Science
2023/04/01 → 2026/03/31
Project: Research Project
-
Tm mapping法による肝硬変腹水中の細菌の同定・定量と自然免疫応答の解析
Tajiri, K. (PI) & Niimi, H. (CoI)
2020/04/01 → 2023/03/31
Project: Research
-
Analysis of HBsAg and its immune response with novel high sensitivity method
Tajiri, K. (PI)
2017/04/01 → 2021/03/31
Project: Research
-
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection
Tajiri, K., Hayashi, Y., Murayama, A., Muraishi, N., Minemura, M. & Yasuda, I., 2025/01, In: Viruses. 17, 1, 44.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
Naganuma, A., Kakizaki, S., Hiraoka, A., Tada, T., Hatanaka, T., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Tsuji, K., Ishikawa, T., Tajiri, K., Toyoda, H., Ogawa, C., Nishikawa, H., Nishimura, T., Kawata, K. & Kosaka, H. & 23 others, , 2025/01, In: Cancer Medicine. 14, 2, e70618.Research output: Contribution to journal › Article › peer-review
Open Access -
Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
Ohama, H., Hiraoka, A., Tada, T., Hirooka, M., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Tsuji, K., Ishikawa, T., Tajiri, K., Ochi, H., Yasuda, S., Toyoda, H., Ogawa, C., Nishimura, T., Hatanaka, T. & Kakizaki, S. & 25 others, , 2025/12, In: Scientific Reports. 15, 1, 72.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC
the Real-life Practice Experts for HCC (RELPEC) Study Group & the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group, 2025/04, In: Journal of Gastroenterology and Hepatology (Australia). 40, 4, p. 949-959 11 p.Research output: Contribution to journal › Article › peer-review
-
Wilson’s Disease Suspected to Involve a Novel Genetic Mutation of ATP7B Gene, Requiring a Differential Diagnosis with Non-alcoholic Steatohepatitis
Minemura, M., Fukuda, R., Tajiri, K., Muraishi, N., Murayama, A., Hayashi, Y., Takahara, T., Noguchi, A. & Yasuda, I., 2025, In: Internal Medicine. 64, 3, p. 375-379 5 p.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve function
Hiraoka, A. (Contributor), Kumada, T. (Contributor), Tada, T. (Contributor), Hirooka, M. (Contributor), Kariyama, K. (Contributor), Tani, J. (Contributor), Atsukawa, M. (Contributor), Takaguchi, K. (Contributor), Itobayashi, E. (Contributor), Fukunishi, S. (Contributor), Tsuji, K. (Contributor), Ishikawa, T. (Contributor), Tajiri, K. (Contributor), Ochi, H. (Contributor), Yasuda, S. (Contributor), Toyoda, H. (Contributor), Ogawa, C. (Contributor), Nishimura, T. (Contributor), Hatanaka, T. (Contributor), Kakizaki, S. (Contributor), Shimada, N. (Contributor), Kawata, K. (Contributor), Naganuma, A. (Contributor), Kosaka, H. (Contributor), Matono, T. (Contributor), Kuroda, H. (Contributor), Yata, Y. (Contributor), Ohama, H. (Contributor), Tada, F. (Contributor), Nouso, K. (Contributor), Morishita, A. (Contributor), Tsutsui, A. (Contributor), Nagano, T. (Contributor), Itokawa, N. (Contributor), Okubo, T. (Contributor), Arai, T. (Contributor), Yokohama, K. (Contributor), Imai, M. (Contributor), Koizumi, Y. (Contributor), Nakamura, S. (Contributor), Iijima, H. (Contributor), Kaibori, M. (Contributor) & Hiasa, Y. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.23500869.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Lenvatinib_as_second-line_treatment_after_atezolizumab_plus_bevacizumab_for_unresectable_hepatocellular_carcinoma_clinical_results_show_importance_of_hepatic_reserve_function/23500869/1
Dataset
-
Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve function
Hiraoka, A. (Contributor), Kumada, T. (Contributor), Tada, T. (Contributor), Hirooka, M. (Contributor), Kariyama, K. (Contributor), Tani, J. (Contributor), Atsukawa, M. (Contributor), Takaguchi, K. (Contributor), Itobayashi, E. (Contributor), Fukunishi, S. (Contributor), Tsuji, K. (Contributor), Ishikawa, T. (Contributor), Tajiri, K. (Contributor), Ochi, H. (Contributor), Yasuda, S. (Contributor), Toyoda, H. (Contributor), Ogawa, C. (Contributor), Nishimura, T. (Contributor), Hatanaka, T. (Contributor), Kakizaki, S. (Contributor), Shimada, N. (Contributor), Kawata, K. (Contributor), Naganuma, A. (Contributor), Kosaka, H. (Contributor), Matono, T. (Contributor), Kuroda, H. (Contributor), Yata, Y. (Contributor), Ohama, H. (Contributor), Tada, F. (Contributor), Nouso, K. (Contributor), Morishita, A. (Contributor), Tsutsui, A. (Contributor), Nagano, T. (Contributor), Itokawa, N. (Contributor), Okubo, T. (Contributor), Arai, T. (Contributor), Yokohama, K. (Contributor), Imai, M. (Contributor), Koizumi, Y. (Contributor), Nakamura, S. (Contributor), Iijima, H. (Contributor), Kaibori, M. (Contributor) & Hiasa, Y. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.23500869, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Lenvatinib_as_second-line_treatment_after_atezolizumab_plus_bevacizumab_for_unresectable_hepatocellular_carcinoma_clinical_results_show_importance_of_hepatic_reserve_function/23500869
Dataset
-
Supplementary Material for: Relationship of atezolizumab plus bevacizumab treatment with muscle volume loss in unresectable hepatocellular carcinoma patients– multicenter analysis
Hiraoka, A. (Contributor), Kumada, T. (Contributor), Tada, T. (Contributor), Hirooka, M. (Contributor), Kariyama, K. (Contributor), Tani, J. (Contributor), Atsukawa, M. (Contributor), Takaguchi, K. (Contributor), Itobayashi, E. (Contributor), Fukunishi, S. (Contributor), Tsuji, K. (Contributor), Ishikawa, T. (Contributor), Tajiri, K. (Contributor), Ochi, H. (Contributor), Yasuda, S. (Contributor), Toyoda, H. (Contributor), Ogawa, C. (Contributor), Nishimura, T. (Contributor), Hatanaka, T. (Contributor), Kakizaki, S. (Contributor), Shimada, N. (Contributor), Kawata, K. (Contributor), Naganuma, A. (Contributor), Kaibori, M. (Contributor), Tanaka, T. (Contributor), Ohama, H. (Contributor), Nouso, K. (Contributor), Morishita, A. (Contributor), Tsutsui, A. (Contributor), Nagano, T. (Contributor), Itokawa, N. (Contributor), Okubo, T. (Contributor), Arai, T. (Contributor), Imai, M. (Contributor), Koizumi, Y. (Contributor), Nakamura, S. (Contributor), Joko, K. (Contributor), Iijima, H. (Contributor), Kosaka, H. (Contributor), Hiasa, Y. (Contributor) & Kudo, M. (Contributor), Karger Publishers, 2022
DOI: 10.6084/m9.figshare.21695111.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Relationship_of_atezolizumab_plus_bevacizumab_treatment_with_muscle_volume_loss_in_unresectable_hepatocellular_carcinoma_patients_multicenter_analysis/21695111/1
Dataset
-
Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib
Iavarone, M. (Contributor), Alimenti, E. (Contributor), Tada, T. (Contributor), Shimose, S. (Contributor), Suda, G. (Contributor), Yoo, C. (Contributor), Soldà, C. (Contributor), Piscaglia, F. (Contributor), Tosetti, G. (Contributor), Marra, F. (Contributor), Vivaldi, C. (Contributor), Conti, F. (Contributor), Schirripa, M. (Contributor), Iwamoto, H. (Contributor), Sho, T. (Contributor), Lee, S. H. (Contributor), Rizzato, M. D. (Contributor), Tonnini, M. (Contributor), Rimini, M. (Contributor), Campani, C. (Contributor), Masi, G. (Contributor), Foschi, F. (Contributor), Bruccoleri, M. (Contributor), Kawaguchi, T. (Contributor), Kumada, T. (Contributor), Hiraoka, A. (Contributor), Atsukawa, M. (Contributor), Fukunishi, S. (Contributor), Ishikawa, T. (Contributor), Tajiri, K. (Contributor), Ochi, H. (Contributor), Yasuda, S. (Contributor), Toyoda, H. (Contributor), Hatanaka, T. (Contributor), Kakizaki, S. (Contributor), Kawata, K. (Contributor), Tada, F. (Contributor), Ohama, H. (Contributor), Itokawa, N. (Contributor), Okubo, T. (Contributor), Arai, T. (Contributor), Imai, M. (Contributor), Naganuma, A. (Contributor), Casadei-Gardini, A. (Contributor) & Lampertico, P. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.24138684, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138684
Dataset
-
Supplementary Material for: Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
Hiraoka, A. (Creator), Kumada, T. (Creator), Atsukawa, M. (Creator), Hirooka, M. (Creator), Tsuji, K. (Creator), Ishikawa, T. (Creator), Takaguchi, K. (Creator), Kariyama, K. (Creator), Itobayashi, E. (Creator), Tajiri, K. (Creator), Shimada, N. (Creator), Shibata, H. (Creator), Ochi, H. (Creator), Tada, T. (Creator), Toyoda, H. (Creator), Nouso, K. (Creator), Tsutsui, A. (Creator), Nagano, T. (Creator), Itokawa, N. (Creator), Hayama, K. (Creator), Imai, M. (Creator), Joko, K. (Creator), Tanaka, H. (Creator), Tamai, T. (Creator), Koizumi, Y. (Creator), Hiasa, Y. (Creator), Michitaka, K. (Creator) & Kudo, M. (Creator), Karger Publishers, 2019
DOI: 10.6084/m9.figshare.8869625, https://karger.figshare.com/articles/Supplementary_Material_for_Important_Clinical_Factors_in_Sequential_Therapy_Including_Lenvatinib_against_Unresectable_Hepatocellular_Carcinoma/8869625
Dataset
Courses
-
高度先進医療実践学序論
Hayashi, R., Inomata, M., Tajiri, K., Kinugawa, K., Sato, T., Yasuda, I., Chujo, D., Imamura, T., Fujisaka, S. & Shimada, S. 2024/10/02 → 2024/12/03
Course
-
消化器疾患
Takahara, T., Kajiura, S., Minemura, M., Fujinami, H., Yoshioka, I., Shibuya, K., Hirano, K., Tajiri, K., Fujii, T., Yasuda, I., Okabe, M., Ando, T., Naruto, N., Miwa, T., Watanabe, T. & Shimada, S. 2024/10/01 → 2025/03/31
Course
-
-
-